231 related articles for article (PubMed ID: 36066972)
1. Transcriptome and DNA methylome analyses reveal underlying mechanisms for the racial disparity in uterine fibroids.
Paul EN; Grey JA; Carpenter TJ; Madaj ZB; Lau KH; Givan SA; Burns GW; Chandler RL; Wegienka GR; Shen H; Teixeira JM
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36066972
[TBL] [Abstract][Full Text] [Related]
2. Racial disparity in uterine leiomyoma: new insights of genetic and environmental burden in myometrial cells.
Khan NH; McNally R; Kim JJ; Wei JJ
Mol Hum Reprod; 2024 Feb; 30(3):. PubMed ID: 38290796
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
4. Integrated Epigenome, Exome, and Transcriptome Analyses Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids.
George JW; Fan H; Johnson B; Carpenter TJ; Foy KK; Chatterjee A; Patterson AL; Koeman J; Adams M; Madaj ZB; Chesla D; Marsh EE; Triche TJ; Shen H; Teixeira JM
Cell Rep; 2019 Dec; 29(12):4069-4085.e6. PubMed ID: 31851934
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome Analyses of Myometrium from Fibroid Patients Reveals Phenotypic Differences Compared to Non-Diseased Myometrium.
Paul EN; Burns GW; Carpenter TJ; Grey JA; Fazleabas AT; Teixeira JM
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807176
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
7. Evidence that geographic variation in genetic ancestry associates with uterine fibroids.
Keaton JM; Jasper EA; Hellwege JN; Jones SH; Torstenson ES; Edwards TL; Velez Edwards DR
Hum Genet; 2021 Oct; 140(10):1433-1440. PubMed ID: 34302236
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial Stress and MicroRNA Expression Profiles in Myometrial Tissue of Women Undergoing Surgical Treatment for Uterine Fibroids.
Dye CK; Wu H; VanNoy B; Calluori S; Marfori CQ; Baccarelli AA; Zota AR
Reprod Sci; 2024 Jun; 31(6):1651-1661. PubMed ID: 38379067
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in transcriptomics and reactive oxygen species burden in myometrium and leiomyoma.
Li Y; McNally RP; Feng Y; Kim JJ; Wei JJ
Hum Reprod; 2023 Apr; 38(4):609-620. PubMed ID: 36749068
[TBL] [Abstract][Full Text] [Related]
10. The Epidemiology and Genetics of Uterine Leiomyoma.
Styer AK; Rueda BR
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():3-12. PubMed ID: 26725703
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
12. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.
Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.
Navarro A; Yin P; Monsivais D; Lin SM; Du P; Wei JJ; Bulun SE
PLoS One; 2012; 7(3):e33284. PubMed ID: 22428009
[TBL] [Abstract][Full Text] [Related]
14. Incidence and health care burden of uterine fibroids among female service members in the active component of the U.S. Armed Forces, 2011-2022.
Nieh C; Mabila SL
MSMR; 2024 Feb; 31(2):9-15. PubMed ID: 38466970
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract][Full Text] [Related]
16. Role of DNA damage and repair mechanisms in uterine fibroid/leiomyomas: a review.
Toprani SM; Kelkar Mane V
Biol Reprod; 2021 Jan; 104(1):58-70. PubMed ID: 32902600
[TBL] [Abstract][Full Text] [Related]
17. Incidence, aetiology and epidemiology of uterine fibroids.
Okolo S
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):571-88. PubMed ID: 18534913
[TBL] [Abstract][Full Text] [Related]
18. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD
Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840
[TBL] [Abstract][Full Text] [Related]
19. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE
Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Risk Factors of Uterine Fibroids.
Pavone D; Clemenza S; Sorbi F; Fambrini M; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():3-11. PubMed ID: 29054502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
